Skip to main content
Log in

Magnetic resonance imaging features of uterine sarcoma and mimickers

  • Pictorial Essay
  • Published:
Abdominal Radiology Aims and scope Submit manuscript

Abstract

Uterine myometrial tumors are predominantly benign conditions that affect one-third of women and represent the main indication for hysterectomy. Preoperative imaging is of utmost importance for characterization and for precise mapping of myometrial tumors to best guide therapeutic strategy. New minimally invasive therapeutic strategies including morcellation, myolysis, uterine artery embolization and image-guided radiofrequency or focused ultrasound ablation have been developed for the treatment of uterine leiomyoma. However, preoperative differentiation between atypical leiomyomas and leiomyosarcomas is critical on imaging as uterine sarcoma requires a specific surgical technique to prevent dissemination. A single, rapidly growing uterine tumor, associated with endometrial thickening and ascites, in post-menopausal women is suspicious of uterine endometrial stromal sarcoma and carcinosarcoma. Suggestive magnetic resonance imaging features have been described, but overlap in imaging appearance between uterine leiomyosarcomas and cellular leiomyomas makes it challenging to ascertain the diagnosis. This review aims to illustrate the imaging features of uterine sarcomas and potential mimickers to make the reader more familiar with this serious condition which needs special consideration.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10

Similar content being viewed by others

References

  1. Myers ER, Barber MD, Gustilo-Ashby T, et al. (2002) Management of uterine leiomyomata: what do we really know? Obstet Gynecol 100:8–17

    PubMed  Google Scholar 

  2. Jiang X, Thapa A, Lu J, et al. (2014) Ultrasound-guided transvaginal radiofrequency myolysis for symptomatic uterine myomas. Eur J Obstet Gynecol Reprod Biol 177:38–43

    Article  CAS  PubMed  Google Scholar 

  3. Worthington-Kirsch R, Spies JB, Myers ER, et al. (2005) FIBROID investigators, the Fibroid registry for outcomes data (FIBROID) for uterine embolization: short-term outcomes. Obstet Gynecol 106:52–59

    Article  PubMed  Google Scholar 

  4. Tempany CMC, Stewart EA, McDannold N, et al. (2003) MR imaging-guided focused ultrasound surgery of uterine leiomyomas: a feasibility study. Radiology 226:897–905

    Article  PubMed  Google Scholar 

  5. Siedhoff MT, Kim KH (2015) Morcellation and myomas: balancing decisions around minimally invasive treatments for fibroids. J Surg Oncol 112:769–771

    Article  PubMed  Google Scholar 

  6. Major FJ, Blessing JA, Silverberg SG, et al. (1993) Prognostic factors in early-stage uterine sarcoma. a gynecologic oncology group study. Cancer 71:1702–1709

    Article  CAS  PubMed  Google Scholar 

  7. Van den Bosch T, Coosemans A, Morina M, Timmerman D, Amant F (2012) Screening for uterine tumours. Best Pract Res Clin Obstet Gynaecol 26:257–266

    Article  PubMed  Google Scholar 

  8. Koivisto-Korander R, Butzow R, Koivisto A-M, Leminen A (2008) Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: experience in Helsinki University Central Hospital 1990–2001. Gynecol Oncol 111:74–81

    Article  PubMed  Google Scholar 

  9. Tirumani SH, Ojili V, Shanbhogue AKP, et al. (2013) Current concepts in the imaging of uterine sarcoma. Abdom Imaging 38:397–411

    Article  PubMed  Google Scholar 

  10. Zhao W-C, Bi F-F, Li D, Yang Q (2015) Incidence and clinical characteristics of unexpected uterine sarcoma after hysterectomy and myomectomy for uterine fibroids: a retrospective study of 10,248 cases. OncoTargets Ther 8:2943–2948

    Google Scholar 

  11. D’Angelo E, Prat J (2010) Uterine sarcomas: a review. Gynecol Oncol 116:131–139

    Article  PubMed  Google Scholar 

  12. Meredith RF, Eisert DR, Kaka Z, et al. (1986) An excess of uterine sarcomas after pelvic irradiation. Cancer 58:2003–2007

    Article  CAS  PubMed  Google Scholar 

  13. Varela-Duran J, Nochomovitz LE, Prem KA, Dehner LP (1980) Postirradiation mixed müllerian tumors of the uterus: a comparative clinicopathologic study. Cancer 45:1625–1631

    Article  CAS  PubMed  Google Scholar 

  14. Leung F, Terzibachian J-J, Govyadovskiy A, Lassabe C (2009) Postmenopausal pure rhabdomyosarcoma of the uterine corpus associated with previous pelvic irradiation. Arch Gynecol Obstet 279:209–211

    Article  PubMed  Google Scholar 

  15. Hong R, Lim S-C, Jung H (2008) A myxoid liposarcoma arising in a leiomyoma of the uterus: a case report. Arch Gynecol Obstet 277:445–448

    Article  PubMed  Google Scholar 

  16. Kew CCY, Putti TC, Razvi K (2004) Malignant mesenchymoma arising from a uterine leiomyoma in the menopause. Gynecol Oncol 95:712–715

    Article  PubMed  Google Scholar 

  17. Al Ansari AA, Al Hail FA, Abboud E (2013) Malignant transformation of uterine leiomyoma. Qatar Med J 2012:71–74

    PubMed  PubMed Central  Google Scholar 

  18. Hadoux J, Morice P, Lhommé C, et al. (2013) Uterine leiomyosarcoma: epidemiology, pathology, biology, diagnosis, prognosis and treatment. Bull Cancer 100:903–915

    PubMed  Google Scholar 

  19. Rush DS, Tan J, Baergen RN, Soslow RA (2001) h-Caldesmon, a novel smooth muscle-specific antibody, distinguishes between cellular leiomyoma and endometrial stromal sarcoma. Am J Surg Pathol 25:253–258

    Article  CAS  PubMed  Google Scholar 

  20. Wu T-I, Yen T-C, Lai C-H (2011) Clinical presentation and diagnosis of uterine sarcoma, including imaging. Best Pract Res Clin Obstet Gynaecol 25:681–689

    Article  PubMed  Google Scholar 

  21. Wu TI, Hsu KH, Huang HJ, et al. (2008) Prognostic factors and adjuvant therapy in uterine carcinosarcoma. Eur J Gynaecol Oncol 29:483–488

    CAS  PubMed  Google Scholar 

  22. Parker WH, Fu YS, Berek JS (1994) Uterine sarcoma in patients operated on for presumed leiomyoma and rapidly growing leiomyoma. Obstet Gynecol 83:414–418

    CAS  PubMed  Google Scholar 

  23. Nagai T, Takai Y, Akahori T, et al. (2014) Novel uterine sarcoma preoperative diagnosis score predicts the need for surgery in patients presenting with a uterine mass. SpringerPlus 3:678

    Article  PubMed  PubMed Central  Google Scholar 

  24. Nagai T, Takai Y, Akahori T, et al. (2015) Highly improved accuracy of the revised PREoperative sarcoma score (rPRESS) in the decision of performing surgery for patients presenting with a uterine mass. SpringerPlus 4:520

    Article  PubMed  PubMed Central  Google Scholar 

  25. Kawamura N, Ichimura T, Ito F, et al. (2002) Transcervical needle biopsy for the differential diagnosis between uterine sarcoma and leiomyoma. Cancer 94:1713–1720

    Article  PubMed  Google Scholar 

  26. Matsuda M, Ichimura T, Kasai M, et al. (2014) Preoperative diagnosis of usual leiomyoma, atypical leiomyoma, and leiomyosarcoma. Sarcoma 2014:498682

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Tamura R, Kashima K, Asatani M, et al. (2014) Preoperative ultrasound-guided needle biopsy of 63 uterine tumors having high signal intensity upon T2-weighted magnetic resonance imaging. Int J Gynecol Cancer Off J Int Gynecol Cancer Soc 24:1042–1047

    Article  Google Scholar 

  28. Baltarowich OH, Kurtz AB, Pennell RG, et al. (1988) Pitfalls in the sonographic diagnosis of uterine fibroids. AJR Am J Roentgenol 151:725–728

    Article  CAS  PubMed  Google Scholar 

  29. Aviram R, Ochshorn Y, Markovitch O, et al. (2005) Uterine sarcomas versus leiomyomas: gray-scale and Doppler sonographic findings. J Clin Ultrasound JCU 33:10–13

    Article  PubMed  Google Scholar 

  30. Alcazar JL, Galvan R (2009) Three-dimensional power Doppler ultrasound scanning for the prediction of endometrial cancer in women with postmenopausal bleeding and thickened endometrium. Am J Obstet Gynecol 200:44e1–44e6

    Article  Google Scholar 

  31. Spielmann AL, Keogh C, Forster BB, Martin ML, Machan LS (2006) Comparison of MRI and sonography in the preliminary evaluation for fibroid embolization. AJR Am J Roentgenol 187:1499–1504

    Article  PubMed  Google Scholar 

  32. Schwartz LB, Panageas E, Lange R, et al. (1994) Female pelvis: impact of MR imaging on treatment decisions and net cost analysis. Radiology 192:55–60

    Article  CAS  PubMed  Google Scholar 

  33. Hricak H, Tscholakoff D, Heinrichs L, et al. (1986) Uterine leiomyomas: correlation of MR, histopathologic findings, and symptoms. Radiology 158:385–391

    Article  CAS  PubMed  Google Scholar 

  34. Deshmukh SP, Gonsalves CF, Guglielmo FF, Mitchell DG (2012) Role of MR imaging of uterine leiomyomas before and after embolization. Radiogr Rev Publ Radiol Soc N Am Inc 32:E251–E281

    Google Scholar 

  35. Malartic C, Morel O, Rivain A-L, et al. (2013) Evaluation of symptomatic uterine fibroids in candidates for uterine artery embolization: comparison between ultrasonographic and MR imaging findings in 68 consecutive patients. Clin Imaging 37:83–90

    Article  PubMed  Google Scholar 

  36. Murase E, Siegelman ES, Outwater EK, Perez-Jaffe LA, Tureck RW (1999) Uterine leiomyomas: histopathologic features, MR imaging findings, differential diagnosis, and treatment. Radiogr Rev Publ Radiol Soc N Am Inc 19:1179–1197

    CAS  Google Scholar 

  37. Bonneau C, Thomassin-Naggara I, Dechoux S, et al. (2014) Value of ultrasonography and magnetic resonance imaging for the characterization of uterine mesenchymal tumors. Acta Obstet Gynecol Scand 93:261–268

    Article  PubMed  Google Scholar 

  38. Proscia N, Jaffe TA, Neville AM, et al. (2010) MRI of the pelvis in women: 3D versus 2D T2-weighted technique. AJR Am J Roentgenol 195:254–259

    Article  PubMed  Google Scholar 

  39. Goto A, Takeuchi S, Sugimura K, Maruo T (2002) Usefulness of Gd-DTPA contrast-enhanced dynamic MRI and serum determination of LDH and its isozymes in the differential diagnosis of leiomyosarcoma from degenerated leiomyoma of the uterus. Int J Gynecol Cancer Off. Int Gynecol Cancer Soc 12:354–361

    Article  CAS  Google Scholar 

  40. Verma SK, Gonsalves CF, Baltarowich OH, et al. (2010) Spectrum of imaging findings on MRI and CT after uterine artery embolization. Abdom Imaging 35:118–128

    Article  PubMed  Google Scholar 

  41. Sutter O, Soyer P, Shotar E, et al. (2016) Diffusion-weighted MR imaging of uterine leiomyomas following uterine artery embolization. Eur Radiol 26:3558–3570

    Article  PubMed  Google Scholar 

  42. Janvier A, Rousset P, Cazejust J, et al. (2016) MR imaging of pelvic extraperitoneal masses: a diagnostic approach. Diagn Interv Imaging 97:159–170

    Article  CAS  PubMed  Google Scholar 

  43. Qayyum A (2009) Diffusion-weighted imaging in the abdomen and pelvis: concepts and applications. Radiogr Rev Publ Radiol Soc N Am Inc 29:1797–1810

    Google Scholar 

  44. Barral M, Taouli B, Guiu B, et al. (2015) Diffusion-weighted MR imaging of the pancreas: current status and recommendations. Radiology. 274:45–63

    Article  PubMed  Google Scholar 

  45. Namimoto T, Yamashita Y, Awai K, et al. (2009) Combined use of T2-weighted and diffusion-weighted 3-T MR imaging for differentiating uterine sarcomas from benign leiomyomas. Eur Radiol 19:2756–2764

    Article  PubMed  Google Scholar 

  46. Thomassin-Naggara I, Dechoux S, Bonneau C, et al. (2013) How to differentiate benign from malignant myometrial tumours using MR imaging. Eur Radiol 23:2306–2314

    Article  PubMed  Google Scholar 

  47. Tasaki A, Asatani MO, Umezu H, et al. (2015) Differential diagnosis of uterine smooth muscle tumors using diffusion-weighted imaging: correlations with the apparent diffusion coefficient and cell density. Abdom Imaging 40:1742–1752

    Article  PubMed  Google Scholar 

  48. K. Sato, N. Yuasa, M. Fujita, Y. Fukushima, Clinical application of diffusion-weighted imaging for preoperative differentiation between uterine leiomyoma and leiomyosarcoma, Am. J. Obstet. Gynecol. 210 (2014) 368.e1-8.

  49. Takeuchi M, Matsuzaki K, Nishitani H (2009) Hyperintense uterine myometrial masses on T2-weighted magnetic resonance imaging: differentiation with diffusion-weighted magnetic resonance imaging. J Comput Assist Tomogr 33:834–837

    Article  PubMed  Google Scholar 

  50. Tamai K, Koyama T, Saga T, et al. (2008) The utility of diffusion-weighted MR imaging for differentiating uterine sarcomas from benign leiomyomas. Eur Radiol 18:723–730

    Article  PubMed  Google Scholar 

  51. Bharwani N, Newland A, Tunariu N, et al. (2010) MRI appearances of uterine malignant mixed müllerian tumors. AJR Am J Roentgenol 195:1268–1275

    Article  PubMed  Google Scholar 

  52. Ohguri T, Aoki T, Watanabe H, et al. (2002) MRI findings including gadolinium-enhanced dynamic studies of malignant, mixed mesodermal tumors of the uterus: differentiation from endometrial carcinomas. Eur Radiol 12:2737–2742

    PubMed  Google Scholar 

  53. Teo SY, Babagbemi KT, Peters HE, Mortele KJ (2008) Primary malignant mixed mullerian tumor of the uterus: findings on sonography, CT, and gadolinium-enhanced MRI. AJR Am J Roentgenol 191:278–283

    Article  PubMed  Google Scholar 

  54. Shah S, Mortele KJ (2007) Uncommon solid pancreatic neoplasms: ultrasound, computed tomography, and magnetic resonance imaging features. Semin Ultrasound CT MRI 28:357–370

    Article  Google Scholar 

  55. Fujii S, Kaneda S, Tsukamoto K, et al. (2010) Diffusion-weighted imaging of uterine endometrial stromal sarcoma: a report of 2 cases. J Comput Assist Tomogr 34:377–379

    Article  PubMed  Google Scholar 

  56. Furukawa R, Akahane M, Yamada H, et al. (2010) Endometrial stromal sarcoma located in the myometrium with a low-intensity rim on T2-weighted images: report of three cases and literature review. J Magn Reson Imaging JMRI 31:975–979

    Article  PubMed  Google Scholar 

  57. Santos P, Cunha TM (2015) Uterine sarcomas: clinical presentation and MRI features. Diagn Interv Radiol Ank Turk 21:4–9

    Article  Google Scholar 

  58. Gezginç K, Yazici F, Tavli L (2011) Uterine smooth muscle tumors of uncertain malignant potential: a case presentation. Int J Clin Oncol 16:592–595

    Article  PubMed  Google Scholar 

  59. Guntupalli SR, Ramirez PT, Anderson ML, et al. (2009) Uterine smooth muscle tumor of uncertain malignant potential: a retrospective analysis. Gynecol Oncol 113:324–326

    Article  PubMed  Google Scholar 

  60. Cornfeld D, Israel G, Martel M, et al. (2010) MRI appearance of mesenchymal tumors of the uterus. Eur J Radiol 74:241–249

    Article  PubMed  Google Scholar 

  61. Lin G, Yang L-Y, Huang Y-T, et al. (2016) Comparison of the diagnostic accuracy of contrast-enhanced MRI and diffusion-weighted MRI in the differentiation between uterine leiomyosarcoma / smooth muscle tumor with uncertain malignant potential and benign leiomyoma. J Magn Reson Imaging JMRI 43:333–342

    Article  PubMed  Google Scholar 

  62. Prayson RA, Hart WR (1995) Pathologic considerations of uterine smooth muscle tumors. Obstet Gynecol Clin North Am 22:637–657

    CAS  PubMed  Google Scholar 

  63. Yamashita Y, Torashima M, Takahashi M, et al. (1993) Hyperintense uterine leiomyoma at T2-weighted MR imaging: differentiation with dynamic enhanced MR imaging and clinical implications. Radiology. 189:721–725

    Article  CAS  PubMed  Google Scholar 

  64. Soyer P, Harry G, Cazier A, Masselot J, Vanel D (1991) Uterine fibromyolipoma: uncommon imaging features. Eur J Radiol 13:67–68

    Article  CAS  PubMed  Google Scholar 

  65. Maebayashi T, Imai K, Takekawa Y, et al. (2003) Radiologic features of uterine lipoleiomyoma. J Comput Assist Tomogr 27:162–165

    Article  PubMed  Google Scholar 

  66. McDonald AG, Dal Cin P, Ganguly A, et al. (2011) Liposarcoma arising in uterine lipoleiomyoma: a report of 3 cases and review of the literature. Am J Surg Pathol 35:221–227

    Article  PubMed  Google Scholar 

  67. Scurry J, Hack M (1990) Leiomyosarcoma arising in a lipoleiomyoma. Gynecol Oncol 39:381–383

    Article  CAS  PubMed  Google Scholar 

  68. Charest M, Hickeson M, Lisbona R, et al. (2009) FDG PET/CT imaging in primary osseous and soft tissue sarcomas: a retrospective review of 212 cases. Eur J Nucl Med Mol Imaging 36:1944–1951

    Article  PubMed  Google Scholar 

  69. Bazot M, Lafont C, Roussel A, et al. (2010) Soft tissue characterization of the female pelvis with MRI. J Radiol 91:453–464

    Article  CAS  PubMed  Google Scholar 

  70. Okizuka H, Sugimura K, Takemori M, et al. (1993) MR detection of degenerating uterine leiomyomas. J Comput Assist Tomogr 17:760–766

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Matthias Barral.

Ethics declarations

Funding

No funding was received for this study.

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

Statement of informed consent was not applicable since the manuscript does not contain any patient data.

Additional information

I certify that each author has participated sufficiently in the study and the paper to take public responsibility for its content.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Barral, M., Placé, V., Dautry, R. et al. Magnetic resonance imaging features of uterine sarcoma and mimickers. Abdom Radiol 42, 1762–1772 (2017). https://doi.org/10.1007/s00261-017-1076-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-017-1076-9

Keywords

Navigation